Atlas Trials

Breast Inflammatory Carcinoma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Breast Inflammatory Carcinoma

RecordFirmDate
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer (NCT05177796)M.D. Anderson Cancer Center2022-03-11
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer (NCT05041101)M.D. Anderson Cancer Center2021-12-21
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer (NCT03598257)National Cancer Institute (NCI)2019-01-18
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma (NCT03941756)M.D. Anderson Cancer Center2018-08-14
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT03101748)M.D. Anderson Cancer Center2018-02-19
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer (NCT03012100)Academic and Community Cancer Research United2017-03-31
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy (NCT02971748)M.D. Anderson Cancer Center2017-01-26

Track Breast Inflammatory Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.